Interferon Regulatory Factor 4 (IRF4) Is Overexpressed in Human Non‑small Cell Lung Cancer (NSCLC) and Activates the Notch Signaling Pathway

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.7319
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Interferon Regulatory Factor 4 (IRF4)

Science-Business eXchange
2008English

PED Is Overexpressed and Mediates TRAIL Resistance in Human Non-Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2008English

Interferon-Gamma-Inducible Protein 10 (IP-10) Is an Angiostatic Factor That Inhibits Human Non-Small Cell Lung Cancer (NSCLC) Tumorigenesis and Spontaneous Metastases

Journal of Experimental Medicine
MedicineAllergyImmunology
1996English

Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer

Oncotarget
Oncology
2016English

Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Epidermal Growth Factor Receptor Status and Notch Inhibition in Non-Small Cell Lung Cancer Cells

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2015English

Interferon Regulatory Factor 4 Attenuates Notch Signaling to Suppress the Development of Chronic Lymphocytic Leukemia

Oncotarget
Oncology
2016English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine
2018English

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non–Small Cell Lung Cancer

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy